Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Restrepo

Showing results (21-30 of 414) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2013
Healthcare-associated pneumonia: where do we go next?Marcos I Restrepo, Stefano Aliberti
Respirology (Carlton, Vic.)|November 9, 2012
Corticosteroids for pneumonia: are we there yet?Oriol Sibila, Marcos I Restrepo
Emerging Infectious Diseases|September 22, 2000
Antigenic variation in vector-borne pathogensA G Barbour, B I Restrepo
The American Journal of Medicine|March 31, 2010
Health economics of use fluoroquinolones to treat patients with community-acquired pneumoniaMarcos I Restrepo, Christopher R Frei
Respirology (Carlton, Vic.)|May 30, 2013
Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?Juan Felipe Fernandez, Marcos I Restrepo
Respiratory Care|September 26, 2013
Too passive to prevent ventilator-associated pneumoniaJuan Felipe Fernandez, Marcos I Restrepo
Expert Review of Clinical Pharmacology|September 14, 2019
New perspectives in aspiration community acquired PneumoniaAbraham E Rodriguez, Marcos I Restrepo
Cell|September 9, 1994
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genesB I Restrepo, A G Barbour
Chest|December 11, 2017
Bronchiectasis Management: The State of the UnionJames D Chalmers, Marcos I Restrepo
Diabetes Research and Clinical Practice|August 2, 2014
Impact of diabetes on the natural history of tuberculosisBlanca I Restrepo, Larry S Schlesinger
Pageof 42

Showing results (21-30 of 414) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2013
Healthcare-associated pneumonia: where do we go next?Marcos I Restrepo, Stefano Aliberti
Respirology (Carlton, Vic.)|November 9, 2012
Corticosteroids for pneumonia: are we there yet?Oriol Sibila, Marcos I Restrepo
Emerging Infectious Diseases|September 22, 2000
Antigenic variation in vector-borne pathogensA G Barbour, B I Restrepo
The American Journal of Medicine|March 31, 2010
Health economics of use fluoroquinolones to treat patients with community-acquired pneumoniaMarcos I Restrepo, Christopher R Frei
Respirology (Carlton, Vic.)|May 30, 2013
Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?Juan Felipe Fernandez, Marcos I Restrepo
Respiratory Care|September 26, 2013
Too passive to prevent ventilator-associated pneumoniaJuan Felipe Fernandez, Marcos I Restrepo
Expert Review of Clinical Pharmacology|September 14, 2019
New perspectives in aspiration community acquired PneumoniaAbraham E Rodriguez, Marcos I Restrepo
Cell|September 9, 1994
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genesB I Restrepo, A G Barbour
Chest|December 11, 2017
Bronchiectasis Management: The State of the UnionJames D Chalmers, Marcos I Restrepo
Diabetes Research and Clinical Practice|August 2, 2014
Impact of diabetes on the natural history of tuberculosisBlanca I Restrepo, Larry S Schlesinger
Pageof 42